The results indicated that when ZC3HAV1 expression was upregulated, E-cadherin expression decreased, suggesting that ZC3HAV1 might influence the malignant progression of HCC patients by affecting the EMT process (Figure 9. This evidence concerns the gene ZC3HAV1 and hepatocellular carcinoma.